Horizon 2020 Programme
Horizon 2020 Programme has announced the following calls:
- Patient perspective elicitation on benefits and risks of medicinal products, from development through the entire life cycle, to inform the decision-making process by regulators and Health Technology Assessment bodie
| Deadline Date | 13-10-2015 17:00:00 (Brussels local time) |
- Diabetic Kidney Disease Biomarkers (DKD-BM)
| Deadline Date | 13-10-2015 17:00:00 (Brussels local time) |
- Inflammation and AD: modulating microglia function – focussing on TREM2 and CD33
| Deadline Date | 13-10-2015 17:00:00 (Brussels local time) |
- Understanding the role of amyloid imaging biomarkers in the current and future diagnosis and management of patients across the spectrum of cognitive impairment (from pre-dementia to dementia
|
Deadline Date |
13-10-2015 17:00:00 (Brussels local time) |
- Evolving models of patient engagement and access for earlier identification of Alzheimer’s disease: Phased expansion study
|
Deadline Date |
13-10-2015 17:00:00 (Brussels local time) |
- From ApoE biology to validated Alzheimer’s disease targets
|
Deadline Date |
13-10-2015 17:00:00 (Brussels local time) |
For any questions apply to Management and Innovation Research Department, Atchabarov Research Institute of Fundamental and Applied Medicine
office # 309
phone: (8727) 3387090 ex. (7125)
Aigul Akanova
